Pharmaceutical company plans 14-acre expansion in Oceanside corporate center

Date Published07/10/2023
Author NamePhil Diehl

Additional Reshoring Information:

Company/Division name Gilead Sciences Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2023
Domestically, the work will be done:In-house
Capital investment ($):132.5
City reshored to:Oceanside
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredpharmaceuticals
What domestic positive factors made reshoring more attractive?Infrastructure, Skilled workforce availability/training
Find Reshoring Articles